PRO MEDICUS LIMITED — AGM Information 2011

Nov 17, 2011

==> picture [780 x 136] intentionally omitted <==

Annual General Meeting November 2011

==> picture [780 x 136] intentionally omitted <==

Chairman’s Address AGM 2011

==> picture [246 x 60] intentionally omitted <==

==> picture [211 x 288] intentionally omitted <==

• Overview

• Non Executive Directors

• Mel Ward Scholarship

• CEO/Management Team

==> picture [776 x 28] intentionally omitted <==

==> picture [780 x 136] intentionally omitted <==

Annual General Meeting CEO Address

==> picture [780 x 136] intentionally omitted <==

Year in Review

==> picture [211 x 288] intentionally omitted <==

• One of the most difficult years in company’s history.

• • Revenue and Profit negatively impacted.

• Number of one-off, legacy factors.

• Currency – large negative impact.

• Delay in release of RIS new technology platform.

==> picture [776 x 28] intentionally omitted <==

Year in Review

==> picture [211 x 288] intentionally omitted <==

• FY2011 to be turning point in cycle

• Continued our investment in R&D

• • Company remains debt free

• Cash reserves of $3.26M (as of 30/6/11)

==> picture [776 x 28] intentionally omitted <==

Milestones – New Technology Platform “Coral”

==> picture [222 x 427] intentionally omitted <==

• New technology platform “Coral” now in pre release • Speed of product development has increased • Technology is leading edge • Feedback from customers – extremely positive • Multi lingual support • One product - suitable for all markets

==> picture [776 x 28] intentionally omitted <==

“Coral” – everything is new !

==> picture [720 x 144] intentionally omitted <==

==> picture [720 x 144] intentionally omitted <==

==> picture [720 x 143] intentionally omitted <==

Milestones - Visage

==> picture [240 x 407] intentionally omitted <==

• Visage 7.0 - leading thin client technology

• • Well positioned in growing 3D PACS market.

• • Highly modular solution: – PACS

• – Universal viewer

• – Referrer distribution

• – Teleradiology/Remote reading.

• Addresses ~ 85% of market:

==> picture [776 x 28] intentionally omitted <==

Milestones - Visage

==> picture [250 x 425] intentionally omitted <==

• Significant ongoing Product development

• • Improved robustness and scalability

• Visage Referrer Access Gateway

• • Visage “Ease” - iPad and iPhone

==> picture [776 x 28] intentionally omitted <==

Milestones – Visage “EASE” Mobile

==> picture [250 x 425] intentionally omitted <==

==> picture [493 x 354] intentionally omitted <==

----- Start of picture text -----

•
Solid year of Product development
•
Improved robustness and scalability
•
Referrer Access Gateway
•
Visage “Ease” - iPad and iPhone
Visage EASE – 1Phone/iPad App
----- End of picture text -----

==> picture [776 x 28] intentionally omitted <==

North America

==> picture [290 x 211] intentionally omitted <==

==> picture [290 x 211] intentionally omitted <==

• Worlds biggest market.

• Visage brand has presence.

• Technology leader in thin client 3D PACS.

• A large number of opportunities.

• Market fragmented and will consolidate.

==> picture [776 x 28] intentionally omitted <==

US – Management Changes

==> picture [234 x 351] intentionally omitted <==

• Brad Levin – General Manger & Global Head of Marketing

• Joined August 2011

• Industry veteran with excellent track record.

• Already having positive impact

• Will lead team at RSNA conference

==> picture [776 x 28] intentionally omitted <==

US – Management Changes

==> picture [227 x 273] intentionally omitted <==

• Bobby Roe – Director of Solutions Architecture and Customer Experience

• Joined October 2011

• Wealth of industry experience.

• To spearhead technical and customer focused activities.

==> picture [776 x 28] intentionally omitted <==

North America – Gaining Momentum

==> picture [261 x 380] intentionally omitted <==

• CDI – Referrer Distribution.

• CIRA - Universal Viewer.

• Imaging Endpoints - Thin client 3D.

• • Rays - Teleradiology.

==> picture [776 x 28] intentionally omitted <==

North America – RSNA 2011

==> picture [676 x 397] intentionally omitted <==

----- Start of picture text -----

•
Worlds biggest market.
•
Visae brand has presence.
•
Technology leader in thin client 3D PACS.
•
Starting to make in roads.
----- End of picture text -----

==> picture [776 x 28] intentionally omitted <==

Australian – Management Changes

• Danny Tauber – General Manger Australia

• Previously Chief Operations Manager

• Has been with the company over 17 years.

• Positive impact on customer services

• Supervising team for Coral roll out in Australia

==> picture [776 x 28] intentionally omitted <==

Europe

==> picture [195 x 423] intentionally omitted <==

• Key growth market.

• Increased emphasis on direct sales channels

• Growing client base Germany, UK and Belgium

• • Opportunities in 2013 NHS PACS refresh.

• Keen interest in other European countries.

==> picture [776 x 28] intentionally omitted <==

European – Management – Malte Westerhoff

==> picture [232 x 299] intentionally omitted <==

• Co Founder and co-developer of Visage platform

• Leads team of 41 people

• Building direct sales capability

• Forming platform for future European growth

==> picture [776 x 28] intentionally omitted <==

European – Management – Detlev Stalling

==> picture [222 x 301] intentionally omitted <==

• Co Founder and co-developer of Visage platform

• Head of R&D

• Heads strong development team

• Responsible for both Visage and Amira R&D

==> picture [776 x 28] intentionally omitted <==

European Opportunities

==> picture [195 x 423] intentionally omitted <==

• Eurozone - financial uncertainty

• May affect health spend in short term

• Purchasing decisions likely to take longer

• Need to form partnerships to address NHS market

• Opportunities for Visage PACS and “Coral”

==> picture [776 x 28] intentionally omitted <==

Pro Medicus – e-health

==> picture [232 x 471] intentionally omitted <==

----- Start of picture text -----

•
•
•
----- End of picture text -----

• Revenue ~ $1.9M per annum.

• Scalable and transaction based.

• Currently only in Australia – potential European and US opportunities.

Pro Medicus – Amira

==> picture [177 x 447] intentionally omitted <==

• 3D Toolkit for Life Sciences

• Sold through Web Store

• Sales still growing strongly - 15% plus pa

• Increases awareness of Visage brand

Visage – OEM Business

==> picture [211 x 287] intentionally omitted <==

• Still important in terms of European revenue

• • Key contracts performing well

• Sales in Europe and US

==> picture [776 x 28] intentionally omitted <==

Visage – OEM Business

• Solid contributor to European revenue

• • Key contracts performing well

• • OEM business to continue in Europe and US

==> picture [781 x 136] intentionally omitted <==

==> picture [780 x 136] intentionally omitted <==

==> picture [780 x 136] intentionally omitted <==

==> picture [780 x 136] intentionally omitted <==

Mel Ward Scholarship

==> picture [780 x 136] intentionally omitted <==

Thank you to our Directors and staff for all of the efforts throughout the year

==> picture [780 x 136] intentionally omitted <==

==> picture [780 x 136] intentionally omitted <==

Annual General Meeting November 2011

==> picture [780 x 136] intentionally omitted <==

RESOLUTION OF SHAREHOLDERS

• Resolution 2 – To adopt the Remuneration Report (non binding)

==> picture [137 x 190] intentionally omitted <==

FOR OPEN 61,090,797 97,237 75.62% 0.12%

AGAINST 19,599,361 24.26%

RESOLUTION OF SHAREHOLDERS

• Resolution 3A – To elect as a Director Roderick Lyle

==> picture [137 x 190] intentionally omitted <==

FOR OPEN AGAINST 80,763,259 337,084 155,637 99.39% 0.41% 0.19%

RESOLUTION OF SHAREHOLDERS

• Resolution 3B – To elect as a Director Mr Peter Kempen

FOR OPEN AGAINST 80,708,094 330,884 25,102 99.28% 0.41% 0.32%

==> picture [137 x 190] intentionally omitted <==

RESOLUTION OF SHAREHOLDERS

• Resolution 4 – Approval of incentive options to Mr Roderick Lyle

==> picture [137 x 190] intentionally omitted <==

FOR OPEN AGAINST 60,814,864 271,054 19,976,201 75.02% 0.33% 24.64%

RESOLUTION OF SHAREHOLDERS

• Resolution 5 – Approval of Long Term Incentive Plan

==> picture [137 x 190] intentionally omitted <==

FOR OPEN 61,041,090 277,254 75.31% 0.34%

AGAINST 19,734,525 24.35%